Childhood leukaemia and intramuscular vitamin K: Findings from a case-control study

British Medical Journal

Volumn 313, Issue 7051, 1996, Pages 204-205

  Ansell, Pat ^a   Bull, Diana ^a   Roman, Eve ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b Leukaemia Research Fund Centre for Clinical Epidemiology   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN K GROUP;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; HUMAN; INFANT; INTRAMUSCULAR DRUG ADMINISTRATION; NEWBORN; ORAL DRUG ADMINISTRATION; POLICY; PRENATAL EXPOSURE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 0030013841     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.313.7051.204     Document Type: Article

References (5)

1. Golding J, Greenwood R, Birmingham K, Mott M. Childhood cancer, intramuscular vitamin K, and pethidine given during labour. BMJ 1992;305:341-6.
2. Ekelund H, Finnström O, Gunnarskog, Källén, Larsson Y. Administration of vitamin K to newborn infants and childhood cancer. BMJ 1993;307:89-91.
3. Draper G, McNinch A. Vitamin K for neonates: the controversy. BMJ 1994:308;867-8.
4. Olsen JH, Hertz H, Blinkenberg K, Verder H. Vitamin K regimens and the incidence of childhood cancer in Denmark. BMJ 1994;308;895-6.
5. Stiller CA, Allen MB, Ebtock EM. Childhood cancer in Britain: the National Registry of Childhood Tumours and incidence rates 1978-87. European J Cancer 1995;202:8-34.